🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The relapse of acute leukemia, MDS and blast phase CML after allogeneic tra...
Status
Completed
Location
Emory University Winship Cancer Institute
Start Date
2007-01
Trial ID
NCT00548847
Treatments Being Tested
The purpose of this study is to compare the efficacy and safety of venetocl...
Status
Completed
Location
Chinese PLA General Hospital
Start Date
2023-03-01
Trial ID
NCT06068621
RATIONALE: Imatinib mesylate may stop the growth of cancer cells by blockin...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2008-10
Trial ID
NCT00509093
Neutropenia, a condition characterized by an abnormally low number of infec...
Status
Completed
Location
University of Iowa Hospitals and Clinics
Start Date
2008-04
Trial ID
NCT00627393
Treatments Being Tested
Background: * PSA (prostate specific antigen) is a protein found on normal...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2009-05-11
Trial ID
NCT00972309
RATIONALE: Chemotherapy, such as busulfan, melphalan, and thiotepa, may des...
Status
Completed
Location
Knight Cancer Institute at Oregon Health and Science University
Start Date
2005-03
Trial ID
NCT00238433
The purpose of this study is to evaluate the effectiveness and safety of ep...
Status
Completed
Location
Multiple Locations
Start Date
2005-02
Trial ID
NCT00210587
Treatments Being Tested
Monoclonal antibodies can locate tumor cells and either kill them or delive...
Status
Completed
Location
Children's Oncology Group
Start Date
2001-01
Trial ID
NCT00005576
Treatments Being Tested
The purpose of the study is to evaluate the anti-tumor activity of LY252335...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2011-08
Trial ID
NCT01416389
Treatments Being Tested
The primary objective was to assess the superiority of darbepoetin alfa ver...
Status
Completed
Location
Research Site
Start Date
2011-12-21
Trial ID
NCT01362140
Treatments Being Tested